Carbamyl aspartate synthesis

Reichard found that carbamyl aspartate synthesis would take place in crude liver preparations if carbamyl phosphate and aspartate were provided and showed that the enzyme responsible, aspartate carbamyltransferase, was not the same as that which formed citrulline, but apparently shared carbamyl phosphate with it. 

Previously, bacterial nutrition studies had indicated that carbamyl aspartate ( ureidosuccinate in the earlier literature) might also be an intermediate in pyrimidine synthesis this compound was also found to be incorporated into orotate by the trappir experiments. 

After it became apparent that carbamyl aspartate was an intermediate in orotate synthesis, Reichard 20) investigated the synthesis of carbamyl aspartate in rat liver preparations and demonstrated its formation from aspartate, carbon dioxide, and ammonia, in the presence of ATP and iV-acetylglutamate. Previously, Grisolia and Ck)hen 21) had proposed that an active carbamyl was involved in citrulline synthesis in mammalian liver preparations ... 

An early form of therapy involves eliminating the substrate either by excluding the substrate from the diet, as in phenylketonuria, or by administering drugs—such as penicillamine in Wilson s disease or allopurinol in gout. Orotic aciduria can be corrected by the administration of uridine, which provides the substrate for the biosynthesis of the nucleosides used in RNA and DNA synthesis and is also a substrate for the biosynthesis of inhibitors of the carbamyl aspartate synthetase, the first enzyme in the formation of orotic acid. By this feedback inhibition, the levels of orotic acid in the urine are reduced by the administration of uridine. 

Two separation procedures were used to identify all products that could be formed from [4-aspartate. With the HVPE the end-product, OA, could be separated from the substrate and all other products, including citric acid cycle intermediates. Malate and fuma-rate had the same mobility as carbamyl aspartate and DHO, respectively, but could be separated by TLC. The identity of OA was confirmed by conversion of eluted radioactivity with partially purified yeast OPRT and ODC to OMP and UMP. With brain cortex the rate of OA synthesis from aspartate was 52 12 and with liver 179 35 nmol/h per g wet tissue (means SD of 7 and 4 experiments, respectively) expressed per mg protein these values were 0.81 0.21 and 1.12 0.46, respectively. With both tissues about 10% of the label was found in citric acid cycle intermediates, and with cortex and liver about 1% and 10% of radioactivity was recovered as 002 ... 

Carbamyl phosphate acts as a substrate for a system which leads to the synthesis of carbamyl aspartate (ureidosuccinate), a pyrimidine precursor 468-471). The enzyme, which catalyzes the following reaction, has been... 

Animal and bacterial enzymes that utilize or synthesize carbamyl phosphate have activity with acetyl phosphate. Acyl phosphatase hydrolyzes both substrates, and maybe involved in the specific dynamic action of proteins. Ornithine and aspartic transcarbamylases also synthesize acetylornithine and acetyl aspartate. Finally, bacterial carbamate kinase and animal carbamyl phosphate synthetase utilize acetyl phosphate as well as carbamyl phosphate in the synthesis of adenosine triphosphate. The synthesis of acetyl phosphate and of formyl phosphate by carbamyl phosphate synthetases is described. The mechanism of carbon dioxide activation by animal carbamyl phosphate synthetase is reviewed on the basis of the findings concerning acetate and formate activation. 

A second, cytosolic CPS activity (CPSII) occurs in mammals as part of the CAD trifunctional protein that catalyzes the first three steps of pyrimidine synthesis (CPSII, asparate tran-scarbamoylase, and dihydroorotase). The activities of these three enzymes—CPSII, aspartate transcarbamoylase, and dihydroorotase—result in the production of orotic acid from ammonium, bicarbonate, and ATP. CPSII has no role in ureagenesis, but orotic aciduria results from hepatocellular accumulation of carbamyl phosphate and helps distinguish CPSI deficiency from other UCDs. Defects in CPSI classically present with neonatal acute hyperammonemic encephalopathy. The plasma citrulline and urine orotic acid concentrations are both low. A definitive diagnosis can be established by enzyme assay of biopsied liver tissue or by mutation analysis. 

Dihydroorotase catalyzes the intramolecular cyclization of 7V-carbamyl-L-aspartic acid to L-dihydroorotic acid. In mammals, the activity is present in a trifunctional enzyme that catalyzes the first three steps in the de novo synthesis of pyrimidine nucleotides. 

The biomolecular modes of action of ornithine have been the subject of several experimental investigations. Ornithine activates the enzymes carbamylphosphate synthetase and ornithine carbamyl transferase, which are necessary for the liver-specific process of urea synthesis (133,139) this occurs mainly in the periportal hepa-tocytes (= definitive ammonia detoxification). Glutamine synthesis (binding of ammonia to glutamate) takes place predominantly in the perivenous hepatocytes (= transitory ammonia detoxification). Large amounts of glutamate are necessary for this. Aspartate, ornithine... 

The first step in the formation of urea from ammonia is its combination with bicarbonate to form carbamyl phosphate (Fig. 1). This contributes only one nitrogen atom to urea, the other being donated by aspartic acid in the third step of the pathway. A -Acetylglutamate is required as cofactor, and the presence of Mg is essential, ATP being converted to ADP in the process. The reaction is catalyzed by carbamyl phosphate synthetase (carbamate kinase EC 2.7.2.2). It has been shown that there are probably two forms of this enzyme, at least in rat liver. One is ammonia dependent, is primarily associated with mitochondria, and may be the enzyme responsible for the formation of carbamyl phosphate in the synthesis of urea. The other, which is glutamine dependent, is probably mainly extramitochondrial and may supply the carbamyl phosphate used... 

The utilization of ammonia resulting from the combination of carbamyl phosphate with aspartic acid, the initial reaction for the synthesis of the pyrimidine nucleotides, continues only as long as there is a requirement for them (Fig. 3). Regulation of this biosynthetic pathway is probably by way of feedback inhibition of aspartate transcarbamylase. The rat liver enzyme is inhibited by uridine, cytidine or thymidine or such derivatives as CMP, UTP, or TMP, all intermediates or products of this pathway (B8). This is not the only enzyme of the pathway which may be subject to feedback regulation. Dihydroorotase from rat liver is also inhibited by some pyrimidines and purines (B9). 

The primary step in the urea cycle is the synthesis of carbamyl phosphate from ammonia and carbon dioxide (11.76). This first stage, and the later stage of synthesis of arginosuccinic acid from citrulline and aspartic acid, both require the transfer of energy from ATP hydrolysis. The pyrophosphate formed in the latter reaction is itself hydrolysed which, together with the former reaction. 

Another form of spatial organization of metabolism that is often seen in eukaryotes but is less common in bacteria involves enzyme aggregates or multifunctional enzymes. An example is seen in S. cerevisiae where the first two reactions in pyrimidine nucleotide biosynthesis, the synthesis of carbamyl phosphate and the carbamylation of aspartate, are catalyzed by a single bifunctional protein (31). Both reactions are subject to feedback inhibition by UTP, in contrast to the situation inB. subtilis where aspartate transcarbamylase activity is not controlled. It is possible that an evolutionary advantage of the fusion of the genes... 

The overall capacity of pyrimidine nucleotide de novo synthesis appears to be higher in rat liver than in rat brain. This can also be concluded from the higher activities of carbamyl phosphate synthetase II and aspartate transcarbamylase in liver (2,4). The liver primarily depends on the de novo pathway for nucleotide synthesis. With liver slices pyrimidine nucleotides are predominantly derived from OA uridine is mainly catabolyzed to uracil and 3-alanine (16) in agreement with high activity of uridine phosphorylase. With brain slices uridine was superior to CO2 or OA in labelling RNA (8). This concords with the relatively high activity of uridine kinase. In vivo, however, cytidine appears to be a more important substrate for nucleotide synthesis (17), since uridine in predominantly catabolyzed by various tissues, including liver. 

Cases are known, however, where Drosophila genes coding for one family of isozymes are linked. The classical example is the rudimentary locus (1-54.5). This locus contains genes which control the synthesis of the functionally related enzymes aspartate carbamyl transferase (ACT), carbamyl phosphate synthetase... 

The Biosynthesis of the Pyrimidine Ring begins with aspartic acid and carbamyl phosphate. The latter is an energy-rich compound which reacts with the former to give carbamylaspartic acid. Ring closure consumes ATP and is in principle an acid amide formation (peptide synthesis). The intermediate dihydro-orotic acid is dehydrogenated to orotic acid, probably by action of a flavoprotein. Orotic acid is the key precursor of pyrimidine nucleotides. It reacts with phosphoribosyl pyrophosphate. The removal of pyrophosphate yields the nucleotide of orotic acid, whose enzymic decarboxylation produces uridine 5 -phosphate. Phosphorylation with ATP yields uridine pyrophosphate and, finally, uridine triphosphate. Beside the above pathway, there is the further possibility of converting free uracil and ribose 1-phosphate to the nucleoside and from there with ATP to the nucleotide. 

In other cases we encounter not induction but repression of enzyme synthesis by a metabolite in whose synthesis the enzyme is concerned (the same may also be inhibited in its activity by other components of the reaction sequence in which it it involved, see p. 252). The enzyme whose activity is lost or markedly reduced is not necessarily that which completes the synthesis of the repressor molecule (i.e. not that catalysing the last reaction of the biosynthetic pathway). For instance, uracil can suppress, in certain strains of the bacterium, Escherichia coU, the activity of the enzyme aspartate carbamyl-transferase which promotes the interaction between aspartic acid and carbamyl phosphate, a reaction which is the first step in the reaction sequence involved in pyrimidine biosynthesis. Further, the experimental evidence indicates that the uracil acts as a repressor by preventing synthesis of the enzyme. 

---